Company Overview of QR Pharma, Inc.
QR Pharma, Inc. develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases. It offers Posiphen compound for mild cognitive impairment and early stage Alzheimer's disease; and Bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. QR Pharma, Inc. was founded in 2008 and is based in Berwyn, Pennsylvania.
1055 Westlakes Drive
Berwyn, PA 19312
Founded in 2008
Key Executives for QR Pharma, Inc.
QR Pharma, Inc. Key Developments
Similar Private Companies By Industry
|Pradama Inc.||United States|
|Targeted Cell Therapies LLC||United States|
|Synthon Pharmaceuticals, Inc.||United States|
|Genemed Biotechnologies, Inc.||United States|
|Trinity Therapeutics, Inc.||United States|
Recent Private Companies Transactions
December 19, 2014
To contact QR Pharma, Inc., please visit www.qrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.